European Pharmaceutical Review

MARCH 9, 2023

” Highly potent APIs are pharmacologically and biologically active compounds at low doses. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs). Based on the latest report and data, HPAPI market size is expected to reach $32 billion by 2028.

Compounding 98

Compounding Dosage Communication 98

Pharmaceutical Technology

FEBRUARY 13, 2023

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. GlobalData’s analyst consensus forecast database estimates peak annual sales for ARV-110 of $325 million in 2028.

Dosage 59

Dosage Chemotherapy Compounding Immunization 59

Express Pharma

APRIL 10, 2025

Key parameters, such as pressure and orifice size, are carefully calibrated to achieve accurate drug delivery at the desired depth and dosage, making it a safe and efficient alternative to traditional needle injections. billion in 2028, growing at a compound annual growth rate (CAGR) of 14.16

Vaccines 82

Vaccines Hospitals Packaging Dosage 82

PharmaTech

JUNE 12, 2025

billion and an additional $2 billion in non-contingent anniversary payments through 2028. billion (1). billion (1). This news comes just 10 days after BioNTech announced a global co-development and co-commercialization agreement valued at up to $11.1 billion for BNT327 (2). BioNTech is also eligible to receive up to $7.6 References 1.

Dosage 52

Dosage Drug Development Vaccines Packaging 52